Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 19, 2014
Highest rating of 100 percent distinguishes company as one of the "Best Places to Work for LGBT Equality"
-
Nov 19, 2014EVOLVE II Trial Represents the First Successful U.S. Pivotal Trial of a Bioabsorbable Polymer Stent
EVOLVE II trial represents the first successful U.S. pivotal trial of a bioabsorbable polymer stent
-
Nov 17, 2014
System designed for the hysteroscopic removal of interuterine fibroids and polyps
-
Nov 13, 2014New CPT Category I Code Facilitates Processing for U.S. Hospitals and Physicians
New CPT Category I code facilitates processing for U.S. hospitals and physicians
-
Nov 5, 2014
Boston Scientific will participate in the upcoming healthcare conference on November 18, 2014. A live webcast and replay will be available.
-
Nov 4, 2014Event will be held in Chicago, Site of the 2014 American Heart Association Scientific Sessions
Event will be held in Chicago, site of the 2014 American Heart Association Scientific sessions
-
Nov 3, 2014Data Will Focus on Long-Term Back Pain Relief Using the Boston Scientific Precision Spectra™ Spinal Cord Stimulator (SCS) System and Highlight Research on Stimulation Waveforms
Data will focus on long-term back pain relief using the Precision Spectra™ Spinal Cord Stimulator (SCS) System and highlight research on stimulation waveforms
-
Oct 30, 2014
Boston Scientific will participate in the upcoming healthcare conference on November 11, 2014. A live webcast and replay will be available.
-
Oct 22, 2014
"We achieved excellent third quarter results,” said Mike Mahoney, Boston Scientific chairman and CEO
-
Oct 21, 2014World's First 32-contact SCS Surgical Leads Designed to Provide More Focused Pain Relief for Patients with Chronic Pain
World's first 32-contact SCS surgical leads designed to provide more focused pain relief for patients with chronic pain
-
Oct 20, 2014First Patient Enrolled in PLATINUM Diversity Trial Evaluating Performance in Women, Black Americans, Latinos/Hispanics, Native Americans and Alaska Natives with Coronary Artery Disease
PLATINUM diversity trial evaluating performance in women, Black Americans, Latinos/Hispanics, Native Americans and Alaska Natives with Coronary Artery Disease
-
Oct 16, 2014The innovative devices allow pacemaker patients access to full body MRI scans in 1.5 Tesla and 3.0 Tesla systems
Innovative devices allow pacemaker patients access to full body MRI scans in 1.5 Tesla and 3.0 Tesla systems
-
Oct 8, 2014Comprehensive Clinical Data from Randomized Trials Reviewed
Comprehensive clinical data from randomized trials reviewed
-
Oct 1, 2014
Boston Scientific will webcast its conference call discussing financial results and business highlights for Q3 ended September 30, 2014. Learn how to tune in.
-
Sep 23, 2014Data From REPRISE III Clinical Trial Designed to Support U.S. Regulatory Approval
Data from REPRISE III clinical trial designed to support U.S. regulatory approval
-
Sep 17, 2014Vercise DBS System is the First DBS System Offering Precise Neural Targeting and a 25-Year Battery Life
First DBS system to offer precise neural targeting and a 25-year battery life
-
Sep 15, 2014No Cases of Moderate or Severe Paravalvular Aortic Regurgitation at One Year
No cases of moderate or severe paravalvular aortic regurgitation at one year
-
Sep 10, 2014Data Will Focus on Areas of Significant Unmet Patient Need, Including Coronary Artery Disease and Aortic Valve Disease
Data will focus on areas of significant unmet patient need, including Coronary Artery Disease and Aortic Valve Disease
-
Sep 3, 2014
Boston Scientific will participate in the upcoming healthcare conference on September 17, 2014 in London
-
Sep 2, 2014
Acquisition allows Boston Scientific to offer a more complete portfolio of solutions to treat challenging vascular conditions
-
Aug 30, 2014Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure
Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure
-
Aug 25, 2014
Boston Scientific will participate in the healthcare conference on September 8 in New York
-
Aug 19, 2014Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator™ RotaWire™
Companies reach agreement to develop a new and differentiated FFR guidewire and next generation Boston Scientific Rotablator™ RotaWire™
-
Jul 24, 2014
"We had a strong second quarter, delivering balanced growth across our divisions," said CEO Mike Mahoney
-
Jul 23, 2014Innovative Technology Adds To Company's Leading Portfolio of Treatment Options for Coronary Artery Disease
Innovative technology adds to company's leading portfolio of treatment options for Coronary Artery Disease